+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Inflammation Drug"

From
Psoriatic Arthritis Treatment Market Report 2025 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Corticosteroids Market Report 2025 - Product Thumbnail Image

Corticosteroids Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Hydroxychloroquine Market Report 2025 - Product Thumbnail Image

Hydroxychloroquine Market Report 2025

  • Report
  • April 2025
  • 250 Pages
  • Global
From
Lupus Therapeutics Market Report 2025 - Product Thumbnail Image

Lupus Therapeutics Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
Crohn's Disease (CD) Treatment Market Report 2025 - Product Thumbnail Image

Crohn's Disease (CD) Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Axial Spondyloarthritis (AxSpA) Market Report 2025 - Product Thumbnail Image

Axial Spondyloarthritis (AxSpA) Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Rheumatoid Arthritis Drugs Market Report 2025 - Product Thumbnail Image

Rheumatoid Arthritis Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Gout Therapeutics Market Report 2025 - Product Thumbnail Image

Gout Therapeutics Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Non-Steroidal Anti-inflammatory Drugs Market Report 2025 - Product Thumbnail Image

Non-Steroidal Anti-inflammatory Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ibuprofen API - Global Strategic Business Report - Product Thumbnail Image

Ibuprofen API - Global Strategic Business Report

  • Report
  • May 2025
  • 139 Pages
  • Global
From
Hydroxychloroquine - Global Strategic Business Report - Product Thumbnail Image

Hydroxychloroquine - Global Strategic Business Report

  • Report
  • May 2025
  • 293 Pages
  • Global
From
From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • May 2025
  • 413 Pages
  • Global
From
From
From
Loading Indicator

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems. Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea. Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more